These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10878185)

  • 1. Muscular dystrophy.
    Roland EH
    Pediatr Rev; 2000 Jul; 21(7):233-7; quiz 238. PubMed ID: 10878185
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of Duchenne muscular dystrophy (DMD) for the pediatricians in the community.
    Verma S; Anziska Y; Cracco J
    Clin Pediatr (Phila); 2010 Nov; 49(11):1011-7. PubMed ID: 20724320
    [No Abstract]   [Full Text] [Related]  

  • 3. Approaching therapies for boys with Duchenne muscular dystrophy. Parent Project Muscular Dystrophy. Annual conference in Cincinnati/Ohio, 13-16 July 2006.
    Scheuerbrandt G
    Acta Myol; 2006 Oct; 25(2):77-97. PubMed ID: 18593009
    [No Abstract]   [Full Text] [Related]  

  • 4. Duchenne muscular dystrophy.
    Biggar WD
    Pediatr Rev; 2006 Mar; 27(3):83-8. PubMed ID: 16510548
    [No Abstract]   [Full Text] [Related]  

  • 5. Duchenne muscular dystrophy.
    Annexstad EJ; Lund-Petersen I; Rasmussen M
    Tidsskr Nor Laegeforen; 2014 Aug; 134(14):1361-4. PubMed ID: 25096430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the management of Duchenne muscular dystrophy.
    Manzur AY; Kinali M; Muntoni F
    Arch Dis Child; 2008 Nov; 93(11):986-90. PubMed ID: 18667451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An overview of Duchenne muscular dystrophy in Martinique].
    Sarrazin E; Valard-Giguet AG; Leturcq F; Bellance R
    Med Sci (Paris); 2018 Nov; 34 Hors série n°2():45-48. PubMed ID: 30418149
    [No Abstract]   [Full Text] [Related]  

  • 8. Duchenne muscular dystrophy: a 30-year population-based incidence study.
    Dooley J; Gordon KE; Dodds L; MacSween J
    Clin Pediatr (Phila); 2010 Feb; 49(2):177-9. PubMed ID: 20080524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in steroid therapy for Duchenne muscular dystrophy in Japan.
    Takeuchi F; Komaki H; Nakamura H; Yonemoto N; Kashiwabara K; Kimura E; Takeda S
    Muscle Nerve; 2016 Oct; 54(4):673-80. PubMed ID: 26910583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duchenne and Becker muscular dystrophies.
    Flanigan KM
    Neurol Clin; 2014 Aug; 32(3):671-88, viii. PubMed ID: 25037084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurology Care, Diagnostics, and Emerging Therapies of the Patient With Duchenne Muscular Dystrophy.
    Leigh F; Ferlini A; Biggar D; Bushby K; Finkel R; Morgenroth LP; Wagner KR
    Pediatrics; 2018 Oct; 142(Suppl 2):S5-S16. PubMed ID: 30275245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete atrioventricular block in Becker muscular dystrophy.
    Akdemir R; Ozhan H; Gunduz H; Yazici M; Erbilen E; Uyan C; Imirzalioglu N
    N Z Med J; 2004 May; 117(1194):U895. PubMed ID: 15156213
    [No Abstract]   [Full Text] [Related]  

  • 13. Duchenne muscular dystrophy: the effect of glucocorticoids on ventilator use and ambulation.
    Bach JR; Martinez D; Saulat B
    Am J Phys Med Rehabil; 2010 Aug; 89(8):620-4. PubMed ID: 20647779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy.
    Daftary AS; Crisanti M; Kalra M; Wong B; Amin R
    Pediatrics; 2007 Feb; 119(2):e320-4. PubMed ID: 17272595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal height and weight in a series of ambulant Duchenne muscular dystrophy patients using the 10 day on/10 day off prednisone regimen.
    ten Dam K; de Groot IJ; Noordam C; van Alfen N; Hendriks JC; Sie LT
    Neuromuscul Disord; 2012 Jun; 22(6):500-4. PubMed ID: 22390890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology insight: therapy for Duchenne muscular dystrophy-an opportunity for personalized medicine?
    Lim LE; Rando TA
    Nat Clin Pract Neurol; 2008 Mar; 4(3):149-58. PubMed ID: 18268530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Duchenne's muscular dystrophy: epidemiology, genetics, diagnosis].
    Beauvais P
    Rev Prat; 2001 Sep; 51(13):1473-6. PubMed ID: 11601078
    [No Abstract]   [Full Text] [Related]  

  • 19. [Detecting carriers of a deletion in the dystrophin gene in families with a single case of Duchenne/Becker muscular dystrophy].
    Bisko M; Zimowski JG; Hoffman-Zacharska D; Hausmanowa-Petrusewicz I; Fidziańska E; Zaremba J
    Neurol Neurochir Pol; 1999; 33(6):1261-7. PubMed ID: 10791028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study.
    McDonald CM; Henricson EK; Abresch RT; Duong T; Joyce NC; Hu F; Clemens PR; Hoffman EP; Cnaan A; Gordish-Dressman H;
    Lancet; 2018 Feb; 391(10119):451-461. PubMed ID: 29174484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.